I期非小细胞肺癌患者立体定向放射治疗的真实世界急性毒性和90天死亡率

文章预览

SCI 20 August 2024 Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy (Journal of Thoracic Oncology; IF:21.0) van Rossum PSN, Wolfhagen N, van Bockel LW, Coremans IEM, van Es CA, van der Geest AM, De Jaeger KEA, Wachters B, Knol HP, Koppe FLA, Pomp J, Reymen BJT, Schinagl DAX, Spoelstra FOB, Tissing-Tan CJA, Peters M, van der Voort van Zijp NCMG, van der Wel AM, Wiegman EM, Wijsman R, Damhuis RAM, Belderbos JSA, Real-world acute toxicity and 90-day mortality in patients with stage I non-small cell lung cancer treated with stereotactic body radiotherapy., Journal of Thoracic Oncology (2024), doi: https://doi.org/10.1016/j.jtho.2024.07.016. Correspondence to: p.s.n.vanrossum@amsterdamumc.nl Introduction: 介绍 Stereotactic body radiotherapy (SBRT) has firmly established its role in stage I non-small cell lung cancer (NSCLC). Clinical trial results may not fully apply to real-world scenarios. Thi ………………………………